APA (7th ed.) Citation

G, P., GA, L., AJ, M., MT, Z., & R, U. (2024). Mutant KRAS inhibitors enter the scene of precision therapeutics for pancreatic cancer. Journal of gastrointestinal oncology, 15(4), 1996. https://doi.org/10.21037/jgo-24-326

Chicago Style (17th ed.) Citation

G, Pollin, Lomberk GA, Mathison AJ, Zimmermann MT, and Urrutia R. "Mutant KRAS Inhibitors Enter the Scene of Precision Therapeutics for Pancreatic Cancer." Journal of Gastrointestinal Oncology 15, no. 4 (2024): 1996. https://doi.org/10.21037/jgo-24-326.

MLA (9th ed.) Citation

G, Pollin, et al. "Mutant KRAS Inhibitors Enter the Scene of Precision Therapeutics for Pancreatic Cancer." Journal of Gastrointestinal Oncology, vol. 15, no. 4, 2024, p. 1996, https://doi.org/10.21037/jgo-24-326.